This website uses cookies. By continuing you are agreeing to our privacy policy.

David Shackelford, Ph.D.

Research Awards Nationwide Recipient (2014-2016)

University of California, Los Angeles
Selectively Targeting Metabolic Needs Unique to Lung Cancer
Momentum Award, American Lung Association Bonnie J Addario Momentum Research Award
Funded in Partnership with the Bonnie J. Addario Foundation

Many women with lung cancer bear mutations in the epidermal growth factor receptor (EGFR) gene that drives cancer. For the majority of women with EGFR mutant lung tumors, the initial response to treatment that targets the mutation is temporary, eventually developing a resistance to the treatment. We are testing drugs that inhibit the tumor's ability to metabolize nutrients such as glucose and amino acids. The restriction of metabolism causes an energetic crisis in the tumor cells and kills the cancer cells while preserving the health of the normal surrounding tissue. We will tailor precise therapies to inhibit tumor cell metabolism and growth. This approach represents a new strategy for the treatment of this disease as we move toward developing personalized therapeutic strategies that selectively target the metabolic needs unique to the patient's lung tumor(s) as a novel way of overcoming therapy resistance.

Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.